Lumbar Disc Prosthesis Versus Multidisciplinary Rehabilitation; 8-year Follow-up

January 18, 2016 updated by: Kjersti Storheim, Oslo University Hospital

Lumbar Disc Prosthesis Versus Multidisciplinary Rehabilitation in Chronic Back Pain and Localized Degenerative Disc. Long Term Follow-up of a Randomized Multicentre Trial

During the past 25-30 years, surgery with total disc replacement (TDR) has become an option for a selection of patients with chronic low back pain (LBP) traditionally treated conservatively or operated on with spinal fusion. Randomized trials comparing TDR with fusion have found the clinical outcome of TDR at least equivalent to that of fusion, and the only study comparing TDR to non-surgical treatment (The Norwegian TDR study) concludes that TDR is significantly more effective than multidisciplinary rehabilitation (REHAB) after 2 years. However, the long-term effects of TDR in terms of clinical results, costs, reoperation- and revision rate, degenerative changes and prognostic factors have not been investigated in high quality prospective trials. This is very much required since TDR surgery is offered a great number of patients world wide, and is associated with high complexity and risk of serious complications and difficult revision. Hence, the overall aim of the present study is to evaluate the long term (eight years follow-up) effect of The Norwegian TDR study where TDR surgery were compared to modern multidisciplinary rehabilitation in patients with chronic low back pain and localized degenerative disc changes.

Study Overview

Detailed Description

Two-year results of the Norwegian TDR study were published in BMJ in May 2011 (Hellum et al). The current protocol is 8-year follow-up of patients included in the Norwegian TDR study.

Hypothesis of the 8-year follow-up:

Main hypothesis (H0): There are no differences in change between TDR and REHAB for pain and disability measured by Oswestry Disability Index (main outcome), back pain, quality of life, psychological variables, work status, patients satisfaction, drug use, urinary incontinence, and back surgeries after 8 years.

Secondary Hypothesis:

  1. There are no differences in incidence and degree of disc degeneration at adjacent level or facet joint degeneration at index level between groups (radiological analysis).
  2. There is no association between baseline characteristics, pelvic anatomy / sagittal balance (defined by lumbar lordosis, pelvic tilt, pelvic incidence angle and sacral slope), and clinical outcome after TDR.
  3. There is no difference in cost effectiveness between surgery and REHAB 8 years after inclusion to the study.

Statistical analysis:

The investigators will use the same analysis as for 2-years results: two-way ANOVA, mixed model, regression analysis. p<0.05 will be considered statistically significant

Additional analysis (not conducted at 2 years):

  1. cross-overs will receive last value before cross-over/fusion surgery
  2. survival analysis
  3. pelvic anatomy / sagittal balance (defined by lumbar lordosis, pelvic tilt, pelvic incidence angle and sacral slope) will be included in the predictor analysis
  4. Both CT scans and MRI are taken for the evaluation of index level facet arthropathy

Study Type

Interventional

Enrollment (Actual)

151

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Oslo, Norway, 0407
        • Oslo University Hospital Ullevål

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

25 years to 55 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • aged 25-55 years
  • had low back pain as the main symptom for at least 1 year
  • structured physiotherapy or chiropractic treatment for at least 6 months without sufficient effect
  • Oswestry Disability Index (ODI) of at least 30
  • degenerative intervertebral disc changes in L4/L5 and/or L5/S1.Degeneration had to be restricted to the two lower levels. The following degenerative changes were evaluated: at least 40% reduction of disc height, Modic changes type I and/or II, high-intensity zone in the disc, and morphological changes classified as changes in signal intensity in the disc of grade 3 or 4. The disc was classified as degenerative if the first criteria alone or at least two changes were found on magnetic resonance imaging. The discs were independently classified by two observers (orthopaedic surgeon /radiologist). When in disagreement, the images were classified by a third observer and the outcome decided by simple majority.

Exclusion Criteria:

  • Generalized chronic pain syndrome (widespread myofascial pain)
  • Degeneration established in more than two levels. To be classified as a normal disc, the disc height must not be reduced more than 40% and all other criteria of degenerative disc disease aforementioned must be absent. The classification of a normal disc is performed by two independent observers. If disagreement, the pictures will be classified by a third observer and the outcome decided by simple majority.
  • Symptoms of spinal stenosis
  • Disc protrusion or recess stenosis with nerve root affection
  • Spondylolysis
  • Isthmic spondylolisthesis
  • Arthritis
  • Former fracture of L1 - S1
  • Ongoing psychiatric or somatic disease that excludes either one or both treatment alternatives
  • Does not understand Norwegian language, spoken or in writing
  • Drug abuse
  • Osteoporosis
  • Congenital or acquired deformity

Patients were examined by an orthopaedic surgeon and a specialist in physical medicine and rehabilitation together, which had to agree on inclusion.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Surgery
Replacement of the degenerative intervertebral lumbar disc with an artificial lumbar disc device (degeneration had to be restricted to the two lower levels (L4/L5 and/or L5/S1))
The surgical intervention consisted of replacement of the degenerative intervertebral lumbar disc with a artificial lumbar disc device in one or two of the lover lumbal levels (L4/L5 or/and L5/S1). The ProDisc consists of three pieces, two metal endplates and a polyethylene core that is fixed to the inferior endplate when the device is implanted, and is implanted through a retroperitoneal (or transperitoneal) access.
Other Names:
  • ProDisc II, Synthes Spine
Active Comparator: Multidiciplinary rehabilitation
The intervention is based on a treatment model described by Brox et al (Spine 2003;28:1913-1921) and is also described in details by Hellum et al (BMJ, May 2011). It consisted of a cognitive approach and supervised physical exercise and was delivered by a team of physiotherapists and specialists in physical medicine and rehabilitation. The rehabilitation programme lasted for about 60 hours over three to five weeks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Oswestry Disability Index Oswestry Disability Index
Time Frame: Baseline, 6 weeks, 3 months, 6 months, 1, 2 and 8 years after inclusion to trial
Version 2.0
Baseline, 6 weeks, 3 months, 6 months, 1, 2 and 8 years after inclusion to trial

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Low back pain
Time Frame: Baseline, 6 weeks, 3 months, 6 months, 1, 2 and 8 years after inclusion to trial
Measured by a VAS scale (0-100 mm)
Baseline, 6 weeks, 3 months, 6 months, 1, 2 and 8 years after inclusion to trial
EQ-5D
Time Frame: Baseline, 6 weeks, 3 months, 6 months, 1, 2 and 8 years after inclusion to trial
general health status
Baseline, 6 weeks, 3 months, 6 months, 1, 2 and 8 years after inclusion to trial
HSCL-25
Time Frame: Baseline, 3 months, 6 months, 1, 2 and 8 years after inclusion to trial
Hopkins Symptom Check List 25 for emotional distress
Baseline, 3 months, 6 months, 1, 2 and 8 years after inclusion to trial
Work status
Time Frame: Baseline, 6 weeks, 3 months, 6 months, 1, 2 and 8 years after inclusion to trial
Baseline, 6 weeks, 3 months, 6 months, 1, 2 and 8 years after inclusion to trial
Satisfaction with treatment outcome
Time Frame: Baseline, 6 weeks, 3 months, 6 months, 1, 2 and 8 years after inclusion to trial
7 point Likert scale
Baseline, 6 weeks, 3 months, 6 months, 1, 2 and 8 years after inclusion to trial
Satisfaction with care
Time Frame: Baseline, 6 weeks, 3 months, 6 months, 1 and 8 years after inclusion to trial
5 point Likert scale
Baseline, 6 weeks, 3 months, 6 months, 1 and 8 years after inclusion to trial
Drug consumption
Time Frame: Baseline, 6 weeks, 3 months, 6 months, 1, 2 and 8 years after inclusion to trial
Daily, weekly, type
Baseline, 6 weeks, 3 months, 6 months, 1, 2 and 8 years after inclusion to trial
Urinary incontinence
Time Frame: Baseline, 3 months, 6 months, 1, 2 and 8 years after inclusion to trial
Stress incontinence, urge incontinence
Baseline, 3 months, 6 months, 1, 2 and 8 years after inclusion to trial
Back surgeries and multidisciplinary rehabilitation
Time Frame: Baseline, 6 weeks, 3 months, 6 months, 1, 2 and 8 years after inclusion to trial
All surgeries and multidisciplinary rehabilitation due to low back pain will be registered
Baseline, 6 weeks, 3 months, 6 months, 1, 2 and 8 years after inclusion to trial
Disc degeneration
Time Frame: Baseline, 2 and 8 years after inclusion to trial
Disc degeneration at adjacent level
Baseline, 2 and 8 years after inclusion to trial
Facet joint degeneration
Time Frame: Baseline, 2 and 8 years after inclusion to trial
Facet joint degeneration at index level
Baseline, 2 and 8 years after inclusion to trial
Cost-effectiveness
Time Frame: Baseline, 6 weeks, 3 months, 6 months, 1, 2 and 8 years after inclusion to trial
The EQ-5D questionnaire will be used to estimate patient utilities
Baseline, 6 weeks, 3 months, 6 months, 1, 2 and 8 years after inclusion to trial

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time to surgery
Time Frame: From baseline to 8 years after inclusion to the study

For patients randomized to TDR surgery: time to fixation

For patients randomized to REHAB: time to TDR surgery or fixation

From baseline to 8 years after inclusion to the study

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Kjersti Storheim, PhD, Oslo University Hospital Ullevål

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2012

Primary Completion (Actual)

November 1, 2015

Study Completion (Actual)

November 1, 2015

Study Registration Dates

First Submitted

October 2, 2012

First Submitted That Met QC Criteria

October 10, 2012

First Posted (Estimate)

October 11, 2012

Study Record Updates

Last Update Posted (Estimate)

January 20, 2016

Last Update Submitted That Met QC Criteria

January 18, 2016

Last Verified

January 1, 2016

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Low Back Pain

Clinical Trials on Lumbar total disc replacement

Subscribe